1. Home
  2. TSLX vs RDY Comparison

TSLX vs RDY Comparison

Compare TSLX & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSLX
  • RDY
  • Stock Information
  • Founded
  • TSLX 2010
  • RDY 1984
  • Country
  • TSLX United States
  • RDY India
  • Employees
  • TSLX N/A
  • RDY N/A
  • Industry
  • TSLX Investment Managers
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • TSLX Finance
  • RDY Health Care
  • Exchange
  • TSLX Nasdaq
  • RDY Nasdaq
  • Market Cap
  • TSLX 2.1B
  • RDY 2.1B
  • IPO Year
  • TSLX 2014
  • RDY N/A
  • Fundamental
  • Price
  • TSLX $22.39
  • RDY $13.17
  • Analyst Decision
  • TSLX Strong Buy
  • RDY Buy
  • Analyst Count
  • TSLX 6
  • RDY 1
  • Target Price
  • TSLX $23.17
  • RDY $17.00
  • AVG Volume (30 Days)
  • TSLX 435.5K
  • RDY 1.8M
  • Earning Date
  • TSLX 04-30-2025
  • RDY 05-06-2025
  • Dividend Yield
  • TSLX 9.31%
  • RDY 3.63%
  • EPS Growth
  • TSLX N/A
  • RDY 2.68
  • EPS
  • TSLX 2.03
  • RDY 0.75
  • Revenue
  • TSLX $482,526,000.00
  • RDY $3,637,607,642.00
  • Revenue This Year
  • TSLX N/A
  • RDY $17.23
  • Revenue Next Year
  • TSLX $1.15
  • RDY $9.19
  • P/E Ratio
  • TSLX $11.02
  • RDY $17.77
  • Revenue Growth
  • TSLX 10.14
  • RDY 14.74
  • 52 Week Low
  • TSLX $19.50
  • RDY $12.50
  • 52 Week High
  • TSLX $23.67
  • RDY $16.89
  • Technical
  • Relative Strength Index (RSI)
  • TSLX 49.28
  • RDY 45.35
  • Support Level
  • TSLX $22.09
  • RDY $12.50
  • Resistance Level
  • TSLX $22.74
  • RDY $13.85
  • Average True Range (ATR)
  • TSLX 0.31
  • RDY 0.13
  • MACD
  • TSLX 0.01
  • RDY 0.04
  • Stochastic Oscillator
  • TSLX 71.20
  • RDY 48.15

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: